Kahan BD - Search Results

1

Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group.

Kahan BD, Rajagopalan PR, Hall M. Kahan BD, et al. Transplantation. 1999 Jan 27;67(2):276-84. doi: 10.1097/00007890-199901270-00016. Transplantation. 1999. PMID: 10075594 Clinical Trial.

2

Population pharmacokinetics and exposure-response relationships for basiliximab in kidney transplantation. The U.S. Simulect Renal Transplant Study Group.

Kovarik JM, Kahan BD, Rajagopalan PR, Bennett W, Mulloy LL, Gerbeau C, Hall ML. Kovarik JM, et al. Among authors: kahan bd. Transplantation. 1999 Nov 15;68(9):1288-94. doi: 10.1097/00007890-199911150-00012. Transplantation. 1999. PMID: 10573065 Clinical Trial.

3

Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: a 3-year randomized, multicenter, phase III study.

Lorber MI, Mulgaonkar S, Butt KM, Elkhammas E, Mendez R, Rajagopalan PR, Kahan B, Sollinger H, Li Y, Cretin N, Tedesco H; B251 Study Group. Lorber MI, et al. Transplantation. 2005 Jul 27;80(2):244-52. doi: 10.1097/01.tp.0000164352.65613.24. Transplantation. 2005. PMID: 16041270 Clinical Trial.

4

Randomized controlled trial of FTY720 versus MMF in de novo renal transplantation.

Tedesco-Silva H, Pescovitz MD, Cibrik D, Rees MA, Mulgaonkar S, Kahan BD, Gugliuzza KK, Rajagopalan PR, Esmeraldo Rde M, Lord H, Salvadori M, Slade JM; FTY720 Study Group. Tedesco-Silva H, et al. Among authors: kahan bd. Transplantation. 2006 Dec 27;82(12):1689-97. doi: 10.1097/01.tp.0000251718.95622.b3. Transplantation. 2006. PMID: 17198261 Clinical Trial.

5

Sequential determinations of serum interleukin 6 levels as an immunodiagnostic tool to differentiate rejection from nephrotoxicity in renal allograft recipients.

Yoshimura N, Oka T, Kahan BD. Yoshimura N, et al. Among authors: kahan bd. Transplantation. 1991 Jan;51(1):172-6. doi: 10.1097/00007890-199101000-00026. Transplantation. 1991. PMID: 1987687

6

Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group.

Kahan BD, Julian BA, Pescovitz MD, Vanrenterghem Y, Neylan J. Kahan BD, et al. Transplantation. 1999 Nov 27;68(10):1526-32. doi: 10.1097/00007890-199911270-00016. Transplantation. 1999. PMID: 10589950 Clinical Trial.

7

FTY720 and everolimus in de novo renal transplant patients at risk for delayed graft function: results of an exploratory one-yr multicenter study.

Tedesco-Silva H, Lorber MI, Foster CE, Sollinger HW, Mendez R, Carvalho DB, Shapiro R, Rajagopalan PR, Mayer H, Slade J, Kahan BD; FTY720A2202 clinical study group. Tedesco-Silva H, et al. Among authors: kahan bd. Clin Transplant. 2009 Sep-Oct;23(5):589-99. doi: 10.1111/j.1399-0012.2009.01070.x. Epub 2009 Aug 27. Clin Transplant. 2009. PMID: 19719728 Clinical Trial.

8

The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function.

Knight RJ, Kerman RH, Schoenberg L, Podder H, Van Buren CT, Katz S, Kahan BD. Knight RJ, et al. Among authors: kahan bd. Transplantation. 2004 Sep 27;78(6):904-10. doi: 10.1097/01.tp.0000134399.10352.e4. Transplantation. 2004. PMID: 15385812

9

Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients.

Langer RM, Kahan BD. Langer RM, et al. Among authors: kahan bd. Transplantation. 2002 Sep 27;74(6):804-8. doi: 10.1097/00007890-200209270-00012. Transplantation. 2002. PMID: 12364859

10

Phase I and phase II safety and efficacy trial of intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302) for the prevention of acute allograft rejection.

Kahan BD, Stepkowski S, Kilic M, Katz SM, Van Buren CT, Welsh MS, Tami JA, Shanahan WR Jr. Kahan BD, et al. Transplantation. 2004 Sep 27;78(6):858-63. doi: 10.1097/01.tp.0000128857.77893.d2. Transplantation. 2004. PMID: 15385805 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

715 results

Search Page

Filters